{
  "programid": "1112",
  "evaluation": "evaluation/standard",
  "start": [{
    "id": "faculty"
  }], 
  "manifest": [{
    "pages": [
    "main",
    "faculty",
    "video"
    ]
  }],
  "topnav": [{
      "next-control": "Next",
      "headline": "<p>Cystic Fibrosis Advances and Controversies</p>"
    }],
  "footer": [{
      "col-1": {
        "txt": "Privacy",
        "link": "tpl/privacy.html"
      },
      "col-2": {
        "txt": "Feedback",
        "link": "tpl/feedback.html"
      },
      "col-3": {
        "txt": "Get Certificate&nbsp;&#62;",
        "link": "#finalstep"
      },
      "col-4": {
        "txt": "CME Info",
        "link": "tpl/cmeinfo.html"
      }
    }],
  "sitecontent": [
    {
      "id": "main",
      "template": "Main",
      "title": "ProCME - Specialty",
      "headline": "Cystic Fibrosis Advances and Controversies",
      "header": "Select your Specialty",
      "listviewer": [
        "Pulmonology",
        "Other"
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
	{
      "id": "faculty",
      "template": "Content",
      "title": "ProCME - Faculty",
      "headline": "Cystic Fibrosis Advances and Controversies",
      "header": "Presenting Faculty",
      "listmedia": [ 
        {
          "media_name": "Iman R. Sami-Zakhari, MD",
          "media_thumbnail": "collection/ImanSamiZakhari.jpg",
          "media_accreditation": "Pediatric Pulmonology, Children's National Hospital, Fairfax, VA",
          "media_descript": "",
          "media_disclaimer": "Imam R. Sami-Zakhari has no financial interests/relationships or affiliations in relation to this activity"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
	{
      "id": "video",
      "template": "Video",
      "title": "ProCME - Video",
      "headline": "Program Video",
      "header": "Video",
      "details": "",
      "video_url": "//jwpsrv.com/feed/IzCBNLVw.rss",
      "video_autoplay": "false",
      "audio_url": "",
      "audio_autoplay": ""
    },
	 {
      "id": "equestion1",
      "groupid": "99",
      "template": "Question",
      "title": "Course Evaluation",
      "headline": "Evaluation (1 of 5)",
      "question": "Please rate your level of agreement with the following statement: The content of this activity was fair, balanced, and free of commercial bias.",
      "qid":"eval1",
      "type": "single",
      "async-answer":"false",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1",
          "answerstxt": "<p>Strongly Disagree</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Disagree</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Neither Agree nor Disagree</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Agree</p>"
        },
        {
          "answersid": "c5",
          "answerstxt": "<p>Strongly Agree</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "equestion2",
      "groupid": "99",
      "template": "Question",
      "title": "Course Evaluation",
      "headline": "Evaluation (2 of 5)",
      "question": "Please rate your level of agreement with the following statement: The content of this activity was evidence-based.",
      "qid":"eval2",
      "type": "single",
      "async-answer":"false",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1",
          "answerstxt": "<p>Strongly Disagree</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Disagree</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Neither Agree nor Disagree</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Agree</p>"
        },
        {
          "answersid": "c5",
          "answerstxt": "<p>Strongly Agree</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "equestion3",
      "groupid": "99",
      "template": "Question",
      "title": "Course Evaluation",
      "headline": "Evaluation (3 of 5)",
      "question": "This activity has or will improve my (check all that apply)",
      "qid":"eval3",
      "type": "multiplechoice",
      "async-answer":"false",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1",
          "answerstxt": "<p>Knowledge</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Competence</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Performance</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Patient Outcomes</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "equestion4",
      "groupid": "99",
      "template": "Question",
      "title": "Course Evaluation",
      "headline": "Evaluation (4 of 5)",
      "question": "Please rate the likelihood of participating in future activities on this topic presented in a similar format.",
      "qid":"eval4",
      "type": "single",
      "async-answer":"false",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1",
          "answerstxt": "<p>Never</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Not Likely</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Neutral/Not Sure</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Likely</p>"
        },
        {
          "answersid": "c5",
          "answerstxt": "<p>Very Likely</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "equestion5",
      "groupid": "99",
      "template": "Question",
      "title": "Course Evaluation",
      "headline": "Evaluation (5 of 5)",
      "question": "Please rate your level of agreement with the following statement: The content of this activity was fair, balanced, and free of commercial bias.",
      "qid":"eval5",
      "type": "single",
      "async-answer":"false",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1",
          "answerstxt": "<p>Strongly Disagree</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Disagree</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Neither Agree nor Disagree</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Agree</p>"
        },
        {
          "answersid": "c5",
          "answerstxt": "<p>Strongly Agree</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "equestion6",
      "groupid": "99",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Evaluation (Comments)",
      "question": "Please provide any other feedback or comments.",
      "qid":"eval6",
      "type": "freeform",
      "async-answer":"true",
      "skip": "true",
	  "comments": [
        {
          "tag": "textarea",
          "label": "Comments",
          "for": "comments",
          "name": "comments",
          "type": "text",
          "attr": "rows='8' cols='50' autofocus maxlength='250'"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "certificate",
      "groupid": "999",
      "template": "Question",
      "title": "Certificate Request",
      "headline": "Certificate",
      "question": "Please complete the form below to receive your certificate.",
      "qid":"cert",
      "type": "freeform",
      "async-answer":"false",
      "skip": "true",
      "form": [
        {
          "tag": "input",
          "label": "First Name",
          "for": "fname",
          "name": "fname",
          "type": "text",
          "attr": ""
        },
        {
          "tag": "input",
          "label": "Last Name",
          "for": "lname",
          "type": "text",
          "name": "lname",
          "attr": ""
        },
        {
          "tag": "select",
          "label": "Professional Degree",
          "for": "professional",
          "name": "professional",
          "attr": "",
          "options": [
            { "val": "Text1" },
            { "val": "Text4" }
          ]
        },
        {
          "tag": "input",
          "label": "Email",
          "for": "email",
          "type": "email",
          "name": "email",
          "attr": ""
        },
        {
          "tag": "input",
          "label": "Address",
          "for": "address",
          "type": "text",
          "name": "address",
          "attr": ""
        },
        {
          "tag": "input",
          "label": "City",
          "for": "city",
          "type": "text",
          "name": "city",
          "attr": ""
        },
        {
          "tag": "input",
          "label": "Zip/Postal Code",
          "for": "zpcode",
          "type": "text",
          "name": "zpcode",
          "attr": ""
        },
        {
          "tag": "input",
          "label": "State/Province",
          "for": "stateprovince",
          "type": "text",
          "name": "stateprovince",
          "attr": ""
        },
        {
          "tag": "textarea",
          "name": "fname",
          "attr": "rows='4' cols='50' autofocus maxlength='250'"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
	 {
      "id": "prequestion1",
      "groupid": "1",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Pre-test Question",
      "question": "Which of the following gene therapy strategies are currently being evaluated in clinical trials in patients with cystic fibrosis (CF)?",
      "qid":"AAAq1",
      "type": "single",
      "async-answer":"false",
      "skip": "true",
      "answers": [
        {
          "answersid": "c1", "correct":"1", "correct":"1",
          "answerstxt": "<p>Use of lentivirus-based vectors for CFTR gene transfer to airway epithelium</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Use of adeno-associated virus-based vectors for CFTR gene transfer to airway epithelium</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Use of liposomes to transfer plasmids containing a functional CFTR cDNA to airway epithelium</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "prequestion2",
      "groupid": "1",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Pre-test Question",
      "question": "Ivacaftor is a small-molecular-weight compound approved to treat patients with CF with which of the following mutations?",
      "qid":"AAAq2",
      "type": "multiplechoice",
  	  "async-answer":"false",
        "skip": "true",
        "answers": [
          {
            "answersid": "c1", "correct":"1",
            "answerstxt": "<p>F508D</p>"
          },
          {
            "answersid": "c2",
            "answerstxt": "<p>G551D</p>"
          },
          {
            "answersid": "c3",
            "answerstxt": "<p>R117H-CFTR</p>"
          }
        ],
        "audio_url": "",
        "audio_autoplay": ""
    },
    {
      "id": "prequestion3",
      "groupid": "1",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Pre-test Question",
      "question": "Which of the following agents represent “corrector” molecules currently undergoing clinical trials in CF that assist with <i>F508del</i> folding and allow <i>F508del</i> CFTR to be transported to the apical surface of expressing cells?",
      "type": "multiplechoice",
      "qid":"AAAq3",
      "async-answer":"false",
      "skip": "true",
        "answers": [
          {
            "answersid": "c1", "correct":"1",
            "answerstxt": "<p>Ivacaftor</p>"
          },
          {
            "answersid": "c2",
            "answerstxt": "<p>Lumacaftor (VX-809)</p>"
          },
          {
            "answersid": "c3",
            "answerstxt": "<p>VX-661</p>"
          },
          {
            "answersid": "c4",
            "answerstxt": "<p>Both a and b</p>"
          },
          {
            "answersid": "c5",
            "answerstxt": "<p>Both b and c</p>"
          }
        ],
        "audio_url": "",
        "audio_autoplay": ""
    },
    {
      "id": "prequestion4",
      "groupid": "1",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Pre-test Question",
      "question": "<p>Please indicate your level of agreement with the following statement:</p><p><i>In patients with CF, the F508del mutation manifests both Class II and Class III defects, which means that it may be possible to address both functional defects through combined use of a corrector such as VX-809 or VX-661 and a potentiator such as ivacaftor.</i></p>",
      "qid":"AAAq4",
      "type": "single",
      "async-answer":"false",
      "skip": "true",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>Levofloxacin</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Liposomal amikacin</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Colistin</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },    
    {
      "id": "prequestion5",
      "groupid": "1",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "Dry powder formulation of which of the following inhaled antibiotics is currently under investigation in patients with CF?",
      "qid":"AAAq5",
      "type": "single",
      "async-answer":"false",
      "skip": "true",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>Agree</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Disagree</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Not sure</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "postquestion1",
      "groupid": "2",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "Which of the following gene therapy strategies are currently being evaluated in clinical trials in patients with cystic fibrosis (CF)?",
      "qid":"AAAq1",
      "type": "single",
      "async-answer":"true",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1", "correct":"1", "correct":"1",
          "answerstxt": "<p>Use of lentivirus-based vectors for CFTR gene transfer to airway epithelium</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Use of adeno-associated virus-based vectors for CFTR gene transfer to airway epithelium</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Use of liposomes to transfer plasmids containing a functional CFTR cDNA to airway epithelium</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "postquestion2",
      "groupid": "2",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "Ivacaftor is a small-molecular-weight compound approved to treat patients with CF with which of the following mutations?",
      "qid":"AAAq2",
      "type": "multiplechoice",
      "async-answer":"true",
	  "skip": "false",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>F508D</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>G551D</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>R117H-CFTR</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "postquestion3",
      "groupid": "2",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "Which of the following agents represent “corrector” molecules currently undergoing clinical trials in CF that assist with <i>F508del</i> folding and allow <i>F508del</i> CFTR to be transported to the apical surface of expressing cells?",
      "type": "multiplechoice",
      "qid":"AAAq3",
      "async-answer":"true",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>Ivacaftor</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Lumacaftor (VX-809)</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>VX-661</p>"
        },
        {
          "answersid": "c4",
          "answerstxt": "<p>Both a and b</p>"
        },
        {
          "answersid": "c5",
          "answerstxt": "<p>Both b and c</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },
    {
      "id": "postquestion4",
      "groupid": "2",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "<p>Please indicate your level of agreement with the following statement:</p><p><i>In patients with CF, the F508del mutation manifests both Class II and Class III defects, which means that it may be possible to address both functional defects through combined use of a corrector such as VX-809 or VX-661 and a potentiator such as ivacaftor.</i></p>",
      "qid":"AAAq4",
      "type": "single",
      "async-answer":"true",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>Levofloxacin</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Liposomal amikacin</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Colistin</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },    
    {
      "id": "postquestion5",
      "groupid": "2",
      "template": "Question",
      "title": "ProCME - Clinical Practice",
      "headline": "Post-test Question",
      "question": "Dry powder formulation of which of the following inhaled antibiotics is currently under investigation in patients with CF?",
      "qid":"AAAq5",
      "type": "single",
      "async-answer":"true",
      "skip": "false",
      "answers": [
        {
          "answersid": "c1", "correct":"1",
          "answerstxt": "<p>Agree</p>"
        },
        {
          "answersid": "c2",
          "answerstxt": "<p>Disagree</p>"
        },
        {
          "answersid": "c3",
          "answerstxt": "<p>Not sure</p>"
        }
      ],
      "audio_url": "",
      "audio_autoplay": ""
    },    
    {
      "id": "finalstep",
      "template": "Finalstep",
      "title": "Get Certificate",
      "headline": "From Research to Clinical Practice: What’s New in the Treatment of Cystic Fibrosis?",
      "header": "Get Certificate",
      "content": "<p>Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ducimus, excepturi, vero, quidem nisi inventore odit totam quos earum facere iure veritatis magnam nobis necessitatibus voluptates quibusdam recusandae quaerat facilis. Debitis.</p>"
    }
	]
}